Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors

Jason O’Campo, Jane Uyehara-Lock, Ken D. Aldape, Eric C. Burton, Kathleen R. Lamborn, Michael Prados, Mitchel Berger, Peter Forsyth, James Scott, Sandra Passe, Robert B. Jenkins, Joon Uhm, Brian P. O’Neill

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors'. Together they form a unique fingerprint.

Medicine & Life Sciences